« Back
Home /
Parsatuzumab (Anti-EGFL7)

Parsatuzumab (Anti-EGFL7)

Item no.	A2515-25mg
Manufacturer	Selleckchem
CASRN	1312797-14-0
Amount	1 mg x 25
Specific against	other
Available
Information	Parsatuzumab (Anti-EGFL7) is a humanized monoclonal antibody targeting EGFL7. Parsatuzumab selectively blocks the interaction between EGFL7 and endothelial cells, potentially inhibiting vascular regrowth and reducing vascular endothelial growth factor (VEGF) inhibition. MW: 145.5 KD.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 1 mg x 25

available

Delivery expected until 8/30/2024

Express Delivery: Save 3 days

Compare

Add to wishlist

Recommend by mail